M. Coderch Aris, Vicente Torrente Segarra, A. Acosta Pereira, A. Rodríguez De La Serna

Research output: Contribution to journalReview articleResearchpeer-review


This review article describes the efficacy and safety profile of nabumetone either alone, or compared to other non-steroidal anti-inflammatory drugs (NSAIDs). It presents the data published in various medical reviews and articles showing the efficacy of nabumetone as monotherapy in degenerative diseases as well as autoimmune inflammatory diseases. The article recommends its use in view of its excellent safety and easy to comply with dosage regime.
Original languageEnglish
Pages (from-to)207-215
Issue number4
Publication statusPublished - 1 Dec 2007


  • Efficacy
  • Nabumetone
  • Safety

Fingerprint Dive into the research topics of 'Nabumetone'. Together they form a unique fingerprint.

  • Cite this

    Coderch Aris, M., Torrente Segarra, V., Acosta Pereira, A., & Rodríguez De La Serna, A. (2007). Nabumetone. DOLOR, 22(4), 207-215.